NCT01577251Recruiting

The Radiation Oncology Registry and Biosample Repository

Abramson Cancer Center at Penn Medicine

Start Date

6/1/2008

Completion Date

12/1/2030

Summary

The goal of this study is to establish a registry and biosample repository (defined as blood, urine, and tumor specimens) in patients with a cancer and/or benign tumor diagnosis undergoing radiotherapy.

Eligibility Criteria

Age Range: 18 years to No maximum

* Anyone age 18 and above with a cancer and/or benign tumor diagnosis undergoing radiotherapy * Able to sign consent

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Neoplasia

Locations

Virtua Samson Cancer Center

Moorestown, New Jersey 08057

United States

Virtua Health & Wellness Center

Voorhees Township, New Jersey 08043

United States

Lancaster General Hospital

Lancaster, Pennsylvania 17604

United States

University of Pennsylvania

Philadelphia, Pennsylvania 19104

United States

Run studies, or work at a research site?

Corterve helps sites and sponsors reach patients who are looking for trials. It does not determine eligibility and does not promise an enrolment outcome.

For sponsors, CROs and sites

What Corterve sells to organisations, and the anti-kickback constraints it works within.

Services and published prices

Lay summaries for EU CTR Annex V, pre-screen filtration, recruitment-creative regulatory operations, feasibility reporting.

For research sites

One published licence rate, the same for every site, and the fees a site is never charged.